JP2018528259A5 - - Google Patents

Download PDF

Info

Publication number
JP2018528259A5
JP2018528259A5 JP2018521714A JP2018521714A JP2018528259A5 JP 2018528259 A5 JP2018528259 A5 JP 2018528259A5 JP 2018521714 A JP2018521714 A JP 2018521714A JP 2018521714 A JP2018521714 A JP 2018521714A JP 2018528259 A5 JP2018528259 A5 JP 2018528259A5
Authority
JP
Japan
Prior art keywords
composition
seq
nos
growth
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018521714A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018528259A (ja
Filing date
Publication date
Priority claimed from EP15177017.9A external-priority patent/EP3118216A1/en
Application filed filed Critical
Publication of JP2018528259A publication Critical patent/JP2018528259A/ja
Publication of JP2018528259A5 publication Critical patent/JP2018528259A5/ja
Pending legal-status Critical Current

Links

JP2018521714A 2015-07-16 2016-07-18 成長促進性ペプチドおよびその使用 Pending JP2018528259A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15177017.9 2015-07-16
EP15177017.9A EP3118216A1 (en) 2015-07-16 2015-07-16 Cellular growth and proliferation promoting peptides, and uses thereof
PCT/EP2016/067097 WO2017009490A1 (en) 2015-07-16 2016-07-18 Growth promoting peptides and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021008092A Division JP2021073238A (ja) 2015-07-16 2021-01-21 成長促進性ペプチドおよびその使用

Publications (2)

Publication Number Publication Date
JP2018528259A JP2018528259A (ja) 2018-09-27
JP2018528259A5 true JP2018528259A5 (enExample) 2019-08-22

Family

ID=53776325

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018521714A Pending JP2018528259A (ja) 2015-07-16 2016-07-18 成長促進性ペプチドおよびその使用
JP2021008092A Pending JP2021073238A (ja) 2015-07-16 2021-01-21 成長促進性ペプチドおよびその使用
JP2023171296A Pending JP2024001108A (ja) 2015-07-16 2023-10-02 成長促進性ペプチドおよびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021008092A Pending JP2021073238A (ja) 2015-07-16 2021-01-21 成長促進性ペプチドおよびその使用
JP2023171296A Pending JP2024001108A (ja) 2015-07-16 2023-10-02 成長促進性ペプチドおよびその使用

Country Status (12)

Country Link
US (5) US10905734B2 (enExample)
EP (5) EP3118216A1 (enExample)
JP (3) JP2018528259A (enExample)
KR (2) KR102744262B1 (enExample)
CN (2) CN108135960A (enExample)
AU (3) AU2016293135B2 (enExample)
BR (1) BR112018000655A2 (enExample)
CA (2) CA3175595A1 (enExample)
DK (1) DK3590523T3 (enExample)
ES (2) ES3035669T3 (enExample)
MX (2) MX376011B (enExample)
WO (3) WO2017009486A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114650834A (zh) * 2019-08-20 2022-06-21 努里塔斯有限公司 用于治疗肌肉萎缩的肽
FR3114744B1 (fr) * 2020-10-02 2024-01-05 Basf Beauty Care Solutions France Sas Nouvelle utilisation d’un peptide pour améliorer le confort de la peau et/ou des muqueuses et/ou l’apparence des phanères
CN114315970B (zh) * 2022-03-15 2022-07-19 中食都庆(山东)生物技术有限公司 一种具有增肌作用的豌豆肽及其制备方法、药物和应用
FR3141066A1 (fr) 2022-10-24 2024-04-26 Basf Beauty Care Solutions France Sas Nouvelle utilisation d’un peptide pour améliorer la matrice extracellulaire du derme de la peau et/ou des muqueuses
CN118834269B (zh) * 2024-09-23 2025-02-11 天津科技大学 一种豌豆鲜味肽及其制备方法和应用

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
ES2103366T3 (es) 1991-03-07 1997-09-16 Novo Nordisk As Hidrolizado proteico de guisante, metodo para su produccion y su utilizacion.
US5516642A (en) 1992-11-16 1996-05-14 Bristol-Myers Squibb Company Polypeptides derived from major histocompatibility complex Class I antigen
JP2673659B2 (ja) 1994-02-11 1997-11-05 株式会社ホーネンコーポレーション ペプチド
US5688489A (en) 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
FR2751874B1 (fr) 1996-08-02 1998-08-28 Sederma Sa Nouvelles compositions cosmetiques pour embellir et eclaircir la peau
AU6990796A (en) 1996-08-23 1998-03-06 Sederma Sa Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions
FR2769502B1 (fr) 1997-10-14 2000-04-14 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir du trefle (trifolium sp.)
US20040031072A1 (en) 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
IT1313572B1 (it) 1999-07-27 2002-09-09 Enichem Spa Procedimento per la preparazione di epossidi.
US20110131679A2 (en) * 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
JP2001335596A (ja) * 2000-05-24 2001-12-04 Kenji Sakamoto 新規ペプチド及びその医薬用途
AR035860A1 (es) 2001-04-17 2004-07-21 Femtolink Biotechnologies Llc Metodos de deteccion por espectrometria de masa y cuantificacion de proteinas blanco especificas en muestras biologicas complejas
WO2004042026A2 (en) * 2002-11-04 2004-05-21 Florida State University Research Foundation NUCLEIC ACID AND ALLERGENIC POLYPEPTIDES ENCODED THEREBY IN CASHEW NUTS (Anacardium occidentale)
SE0300795D0 (sv) 2003-03-24 2003-03-24 Isconova Ab Composition comprising iscom particles and live micro-organisms
JP2006526022A (ja) 2003-05-23 2006-11-16 ペスカ バイオメディカル ラボラトリーズ, インク. 重症急性呼吸器症候群及び他のウィルス感染の治療のためのインターフェロンの使用
EP1686957B1 (en) 2003-11-17 2012-03-07 Sederma Compositions containing mixtures of tetrapeptides and tripeptides
US20070053845A1 (en) 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
EP1773400A2 (en) * 2004-07-08 2007-04-18 Amgen Inc. Therapeutic peptides
EP1896496B1 (en) 2005-06-29 2012-01-11 Hadasit Medical Research Services & Development Ltd. Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes
US8105572B2 (en) 2007-05-18 2012-01-31 New York University Method of treating tuberculosis with interferons
KR100759495B1 (ko) * 2006-02-17 2007-09-18 재단법인서울대학교산학협력재단 친수성 생리활성 펩타이드와 소수성 물질을 포함한자기조립 나노구조체
KR101652778B1 (ko) 2006-04-21 2016-08-31 가부시키가이샤 메이지 펩티드를 유효 성분으로서 함유하는 조성물
US20100035803A1 (en) * 2006-05-17 2010-02-11 Dairy Australia Limited Polypeptides and Polynucleotides Encoding the same
US9034402B2 (en) 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
US20110214199A1 (en) * 2007-06-06 2011-09-01 Monsanto Technology Llc Genes and uses for plant enhancement
CN101835799A (zh) 2007-08-24 2010-09-15 麦莱克萨有限公司 超敏反应调节剂
EP2050437A1 (en) 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
WO2011122937A1 (en) * 2010-03-29 2011-10-06 N.V. Nutricia Pea protein peptides with anti helicobacter pylori activity
ES2397890B1 (es) 2011-03-25 2014-02-07 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
EP2793605A1 (en) 2011-12-21 2014-10-29 Laboratorios Ordesa, S.L Process for obtaining rice protein hydrolysates useful in the prevention and/or treatment of obesity
AU2013308409A1 (en) 2012-08-31 2015-03-26 University Of Birmingham Target peptides for immunotherapy and diagnostics
US12374421B2 (en) * 2013-06-10 2025-07-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
WO2015054507A1 (en) * 2013-10-10 2015-04-16 Pronutria, Inc. Nutritive polypeptide production systems, and methods of manufacture and use thereof
US9814670B2 (en) * 2014-12-04 2017-11-14 Mary Kay Inc. Cosmetic compositions
US20170183386A1 (en) 2015-07-16 2017-06-29 Nuritas Limited Peptides, and uses thereof

Similar Documents

Publication Publication Date Title
JP6159084B2 (ja) 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物
JP7330471B2 (ja) 線維症の予防、改善または治療のためのchp(シクロ-ヒスプロ)の用途
JP2018528259A5 (enExample)
CN102846587B (zh) 脂肪酸组合物和植物提取物与药物制剂及其应用
JP2020527134A5 (enExample)
TW201002334A (en) Andrographis paniculata extract
CN105142728A (zh) 用于治疗表面创伤的组合物和方法
JP2015512386A5 (enExample)
JP2012524112A5 (enExample)
JP2017533972A5 (enExample)
US20170183386A1 (en) Peptides, and uses thereof
Basu et al. Toxicity with radiotherapy for oral cancers and its management: A practical approach
CN110381971A (zh) 女性更年期症状改善用组合物
CN114209683A (zh) 壬二酸在制备治疗炎症性肠病药物中的应用
MX2025005597A (es) Compuestos antisenescencia novedosos y composiciones de los mismos
WO2014129818A1 (ko) 당뇨병성 창상의 예방 또는 치료용 약학 조성물
WO2017181978A1 (zh) 贻贝粘蛋白产品及其抑制血管炎症的应用
JP6656890B2 (ja) フィラグリン産生促進剤
CN104771409B (zh) 荭草苷的用途
US20170360882A1 (en) Composition for preventing, improving or treating psoriasis comprising immunomodulator and glucosamine
CN108619486B (zh) 一种治疗皮肤病的软膏剂及其制备方法
WO2017088177A1 (zh) 贻贝粘蛋白产品及其预防和抑制神经炎症的应用
RU2391995C1 (ru) Средство для лечения злокачественных и доброкачественных новообразований различной локализации
KR101574591B1 (ko) 신곡 추출물을 포함하는 상처 치료용 조성물
HK40063175B (zh) 用於预防、改善或治疗纤维化的chp的用途